Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy.

Yoon, Se-Jung

Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy. [electronic resource] - Experimental & molecular medicine Nov 2009 - 802-11 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2092-6413

10.3858/emm.2009.41.11.086 doi


Animals
Aorta--metabolism
Cell Proliferation--drug effects
Cyclooxygenase 2--metabolism
Diabetes Mellitus, Experimental--drug therapy
Diabetic Angiopathies--drug therapy
Glycation End Products, Advanced--metabolism
Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology
Male
Myocytes, Smooth Muscle--metabolism
Oxidative Stress--drug effects
Proto-Oncogene Proteins c-jun--metabolism
Rats
Rats, Sprague-Dawley
Reactive Oxygen Species--metabolism
Signal Transduction--drug effects
Simvastatin--pharmacology
Transcription Factor RelA--metabolism
p38 Mitogen-Activated Protein Kinases--metabolism